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ABSTRACT
Introduction: As the generalized HIV epidemic in specific settings of sub-Saharan Africa con-
tinues to evolve, there is need for evidence-based response to address emerging challenges, 
which include enabling the large number of women living with HIV make informed choices to 
achieve their reproductive goals.
Objectives: This paper seeks to (i) examine the effect of HIV/AIDS on contraceptive method 
choice among women using contraceptives in Kenya; and (ii) identify correlates of contracep-
tive method choice among HIV-positive women practising family planning.
Material and Methods: We apply multinomial Logistic regression models to a sample of 3190 
sexually-active women of reproductive age using contraceptives from the 2003 and 2008 Ke-
nya Demographic and Health Surveys to examine the effect of HIV/AIDS on contraceptive 
method choice. The analysis of correlates of method choice among HIV-positive women is 
based on a sample of 255 HIV-positive women using contraceptives and involves bivariate 
cross-tabulations with Chi-Square tests.
Result: Overall association between HIV status and contraceptive method choice is consistent 
with expected patterns, with women who are HIV-positive being more than twice as likely to 
use condoms rather than hormonal contraceptives, compared to their counterparts of similar 
characteristics who are HIV-negative (p<0.05). Among women infected with HIV, those who 
were previously tested for HIV were more likely to use condoms and less likely to use hor-
monal methods (p<0.05) than those who had never been tested. The higher use of condoms 
by HIV-positive women is only evident among those who had previously been tested for HIV. 
Significant correlates of contraceptive method choice among HIV-positive women include par-
ity, marital status, age group, education and ethnicity. Overall trends suggest a notable shift 
from use of hormonal methods to condoms by HIV-positive women, but predominant use of 
hormonal methods (60%) and low use of condoms (23%) by HIV-positive young women aged 
15-24 practising family planning is of potential concern. 
Conclusion: The findings have important implications for family planning policies/programs 
targeting young women living with HIV and underscore the need to intensify efforts towards 
improved HIV testing coverage to enable HIV-positive women make informed reproductive 
choices. 
KEYWORDS: HIV-positive women; Contraceptive method choice; Demographic and socio-
economic correlates; Multinomial regression analysis; Demographic and health survey; Kenya.
INTRODUCTION
 Kenya has a generalized HIV epidemic, driven primarily by hetero sexual transmis-
sion. According to recent estimates, national HIV prevalence among adults aged 15-64 years 
was 5.6% in 2012, translating to an estimated 1.2 million adults living with HIV.1 Women are 
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disproportionately affected (prevalence of 6.9% for females ver-
sus 4.4% for males in 2012) and wide regional variations exist 
in the country. Despite a recent overall national decline in HIV 
prevalence among adults aged 15-64 in Kenya from 7.2% in 2007 
to 5.6% in 2012, the prevalence in the worst affected region of 
Nyanza Province remained unchanged at about 15% during the 
same period.1 Prevailing trends for women of reproductive age 
(aged 15-49 years) mirror these national patterns-the prevalence 
declined from around 9% in 2003 to 7% in 2012, but remained 
unchanged at about 18% in the highest prevalence region of 
Nyanza province. An earlier study revealed unique reproductive 
experiences of women in the highest HIV prevalence setting of 
Nyanza province,2 suggesting an intricate link between HIV and 
reproductive behaviour. Notwithstanding impressive strides in 
HIV testing and treatment coverage in the country during re-
cent years,3 the number of people living with HIV has remained 
high. It has been noted that as Kenya’s HIV epidemic continues 
to evolve, there is need for continued evidence-based action to 
respond to emerging challenges,4 which include addressing the 
reproductive needs of the large number of women living with 
HIV.
 HIV-positive women have special family planning 
needs. Of particular concern is the apparent greater risk of un-
intended pregnancy among HIV-positive than HIV-negative 
women5,6 which may be attributable to overall lower uptake of 
contraceptives7 or use of less effective methods5 by HIV-positive 
women. These patterns have implications for overall maternal 
and child health in settings of high HIV prevalence such as sub-
Saharan Africa (SSA), including vertical transmission of HIV 
from mother to child. Furthermore, the apparent link of some 
hormonal contraceptives, especially injectables, to increased 
HIV transmission8,9 has important implications for contraceptive 
method choice in high HIV prevalence SSA settings with wide 
spread use and rising popularity of injectables.
 It is important to improve understanding of the extent 
to which HIV-positive women are using suitable family plan-
ning (FP) methods, consistent with their reproductive goals and 
desires. It has been noted that the risks of unprotected sex, sexu-
ally transmitted infections, infertility and unintended pregnancy 
are inextricably linked,10 making the issue of using appropriate 
methods of protection a critical one. Condom use has been rec-
ognized as the mainstay of dual protection of HIV infection and 
unintended pregnancy,11 but acceptability remains low in most 
settings of sub-Saharan Africa (SSA), especially in long-term 
relationships.12 Furthermore, inconsistent condom use has been 
noted as a major cause of concern, leading to unplanned preg-
nancies among women living with HIV.5
 Although all the available reversible methods of con-
traception can generally be used by women at risk of HIV in-
fection and by HIV infected women, hormonal contraception, 
especially injectables, have been linked to increased risk of HIV 
infection and transmission.8,9,13 Therefore, the increasing popu-
larity and dominance of injectable contraceptives in most SSA 
countries14-16 have far-reaching repercussions for contraceptive 
method choice in settings of high HIV risk. Integrated services 
have been linked to increased use of condoms and reduced use 
of other modern contraceptives.17 A better understanding of the 
link between HIV/AIDS and contraceptive method choice in set-
tings adversely affected by HIV/AIDS will help inform effective 
integration of HIV/AIDS and FP services.
 This paper focuses on the association between HIV/
AIDS factors and contraceptive method choice among women 
currently using contraceptives in Kenya. An earlier qualitative 
study in a low contraceptive prevalence setting in Kenya had 
noted that for some HIV-positive women, their HIV status dic-
tated their contraceptive decisions.18 Besides HIV status, other 
HIV/AIDS-related factors, including: HIV risk perception, HIV/
AIDS stigma, HIV/AIDS awareness and previous HIV testing 
are considered of interest as they may also influence individual’s 
contraceptive choice. For instance, it is possible that in settings 
where most individuals do not know their HIV status, perceived 
HIV risk may be a more important determinant of contraceptive 
behaviour than actual HIV status. The specific objectives are to:
(i) examine the effect of HIV/AIDS on contraceptive method 
choice among women in Kenya; and
(ii) identify demographic and socio-economic correlates of 
contraceptive method choice among HIV-positive women 
using family planning.
MATERIAL AND METHODS
The Data
 This study is based on secondary analysis of data from 
the Kenya Demographic and Health Surveys (KDHS) conducted 
in 2003 and 2008.16,19 These two surveys included HIV testing 
for nationally-representative samples, providing a unique op-
portunity to anonymously link HIV test results to the full sur-
vey record at individual level. From an overall sample of 16,639 
women of reproductive age (aged 15-49 years) included in the 
two surveys (8195 in 2003 and 8444 in 2008), a total of 9132 
women (i.e survey respondents residing in every other house-
hold) were eligible for HIV testing. The protocol for HIV testing 
in the two KDHS surveys was as follows:
‘…. all eligible women and men who were interviewed were 
asked to voluntarily provide some drops of blood for HIV test-
ing. ...tested with a Vironostika Anti-HIV-1/2 Plus enzyme-linked 
immunosorbent assay (ELISA) test kit (DADE Behring HIV-1/2) 
for verification purposes. All positive samples and 5 percent of 
negative samples were then tested with a Murex HIV-1/2 Micro 
ELISA System. For quality assurance, all positive samples and a 
10 percent random sample of the negative samples were retested 
at the KEMRI HIV laboratory using the same testing algorithm 
of both Vironostika and Murex Micro ELISA systems. Finally, 
30 discrepant samples were tested by polymerase chain reaction 
(PCR) DNA at KEMRI laboratory’.16(pp. 9-10)
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 Our study sample included all women tested for HIV 
who were using contraceptive methods at the time of the survey 
(27% in 2003 and 39% in 2008), making a total of 3190 respon-
dents (for Objective i analysis). About eight percent of this sam-
ple was HIV-positive, representing a sample of 255 HIV-positive 
women (for Objective ii analysis). The comparative nature of 
DHS data allows for pooling of data across surveys to achieve 
sufficient samples and monitor trends. Pooling data across the 
two surveys is deemed necessary due to the limited size of HIV-
positive sample of women using contraceptives in each of the 
two surveys.
 Contraceptive method choice is the outcome variable 
of interest while HIV/AIDS-related factors (i.e. whether previ-
ously tested for HIV, HIV/AIDS awareness, HIV/AIDS stigma, 
HIV risk perception and sero-status) constitute the key explana-
tory variables. The study takes into consideration a number of 
other key explanatory variables, recognizing that the association 
between HIV/AIDS and contraceptive method choice is likely to 
be influenced by a range of background demographic and socio-
economic moderating factors or confounders associated with 
both HIV/AIDS and contraceptive method choice. A summary 
description of study variables is presented in Table 1. 
METHODS OF ANALYSIS
 The analysis involved both descriptive bivariate analy-
sis and multivariate modelling. Chi-Square tests were used to 
assess significance of bivariate associations in cross-tabulations, 
while multivariate analysis was based on multinomial logis-
tic regression analysis of factors associated with contracep-
tive method choice. The response (dependent) variable in our 
analysis-contraceptive method choice – was classified into four 
mutually exclusive categories: hormonal method (pills and in-
jectables), condoms, periodic abstinence, and other methods 
(mainly sterilization and other long-term methods). Although 
dual use of condoms with other contraceptives was considered 
of particular interest, this was not used as a distinct category 
because of very small numbers. Dual contraceptive methods, 
combining condoms with other methods were classified as ‘con-
doms’, since use of condoms was of particular interest. 
 Preliminary analysis assessed potential clustering of 
contraceptive method choice within communities or clusters, but 
there was no evidence of significant intra-cluster correlations. 
Hence, the analysis was based on single-level rather than multi-
level models. The general equation for the multinomial logistic 
VARIABLE Description
Dependent variable
Contraceptive method choice Current contraceptive method used, classified as: hormonal (pill/injectable); condom; abstinence; and 
other. ‘Other’ comprised mainly sterilization and long-term methods.
HIV/AIDS-related factors
HIV status Binary variable, coded as 1=if respondent is HIV-positive; 0=negative.
Previously tested for HIV Binary variable, coded as 1 if responded was previously tested for HIV; 0=has never been tested
Knows someone with or died of HIV/AIDS Binary variable, coded as 1 if respondent knows someone with or who died of HIV/AIDS; and 0=otherwise.
HIV/AIDS comprehensive knowledge
A composite awareness index derived from a series of questions on misconceptions about HIV/AIDS, 
knowledge of how HIV is transmitted and ways to avoid infection. The resulting score classified into quin-
tiles (1-4), with lowest awareness coded as 1.
HIV/AIDS Stigma A composite index derived from a set of four DHS questions on HIV/AIDS stigma. The resulting score is classified as 0 for ‘low’ stigma or 1 for ‘high’ stigma.
Perceived risk of HIV/AIDS Classified as: 0= no/low risk; or 1= moderate/high perceived risk
Demographic and background socio-economic factors
Respondent’s age Three age-group categories: 15-24, 25-34 and 35+.
Respondent’s parity The total number of children ever born, classified into four categories: 0, 1-2, 3-4 and 5+
Respondent’s marital status Marital or union status at time of survey, classified as: never married, currently married (monogamous/
polygamous), widowed, divorced/separated
Fertility intention Future fertility intention, coded as 1 if respondent wants no more children; 0=otherwise
Recent sexual activity Period since last sex, classified as: within one week, 1-4 weeks, 1-6 months; and more than 6 months
Respondent’s education Highest educational attainment classified into: no formal education; primary level, and secondary and 
above.
Household wealth index DHS composite wealth index20 based on household possessions and amenities, classified into quintiles: 
poorest, poorer, middle; richer and richest
Respondent’s religion Religious affiliation, classified into: Catholic, Protestant/other Christian, and Muslim and other
Respondent’s ethnicity Classified into four categories: Kikuyu, Luo, Luhya and other
Region of residence Seven provinces: Central, Coast, Eastern/North Eastern, Nairobi, Nyanza, Rift Valley and Western
Urban/rural residence Binary variable, coded as 1=urban or; 0=rural residence.
Table 1: A summary description of variables included in the study.
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regression used in the analysis takes the form:
 Log [π(s)/π(r)] = b(s)
0
 + b(s)
1
 X(s)
1 
+ b(s)
2
 X(s)
2 
+ ... +b(s)
k
 X(s)
k ; 
S=2, 3, 4.
Where:
π(s) is the probability of using a particular contraceptive method 
(s); 
π(r) is the probability of using reference-category contraceptive 
method - r=hormonal (1);
b(s)
0
 is the regression intercept/constant for contraceptive method 
(s);
X(s)
1-k 
are covariates for k explanatory variables for contraceptive 
method (s); and
b(s)
1-k
 are the associated usual regression parameter estimates.
 The second part of the analysis focused on HIV-posi-
tive women (Objective ii) and examined factors associated with 
contraceptive method choice among HIV-positive women. Due 
to sample size limitations, this part of the analysis was confined 
to bivariate associations. It was necessary to merge some of the 
categories of explanatory variables with relatively few HIV-pos-
itive women using contraceptives at the time of the survey to 
achieve sufficient samples for valid Chi-Square tests.
RESULTS
Associations between HIV/AIDS and Contraceptive Method 
Choice
 The bivariate associations between HIV/AIDS-related 
factors and contraceptive method choice among current users 
are resented in Table 2. 
 Condom use is higher among HIV-positive women 
(30%) than those who were negative (20%), but hormonal con-
traceptives (pill and injectables) is the predominant method 
among both HIV-infected (42%) and uninfected (49%) women 
currently using contraceptives. Current users who were previ-
ously tested for HIV, had personal acquaintance with HIV/AIDS 
victims or had higher HIV/AIDS awareness are generally more 
likely to use hormonal contraceptives, but less likely to use pe-
HIV/AIDS factor
Method currently used (percent)
Cases 
Hormonal condoms abstain other
HIV sero status**
- Negative
- Positive 
48.9
41.5
20.0
29.5
14.5
14.1
16.7
14.9
2935
255
Previously tested for HIV***
- No
- Yes 
44.6
51.7
19.4
22.0
18.2
10.9
17.8
15.4
1543
1637
Knows someone who has or died of HIV/AIDS**
- No
- Yes 
47.8
48.5
22.8
20.4
17.9
13.8
11.5
17.3
430
2746
HIV/AIDS awareness***
- Lowest
- Lower
- Higher
- Highest 
42.2
47.9
50.2
50.1
23.3
18.7
20.0
22.0
19.5
16.4
14.2
10.1
14.9
16.9
15.7
17.9
463
877
948
902
HIV/AIDS Stigma*
- Low
- high
46.3
50.1
21.4
20.0
15.9
13.1
15.9
16.8
1519
1671
Perceived HIV/AIDS risk***
- Mod-high or has AIDS 
- No-low risk
46.4
51.3
24.8
14.1
13.6
15.7
15.1
18.9
1902
1288
All 48.3 20.7 14.4 16.6 3190
*Chi-Square p<0.05; **p<0.01; ***p<0.001
Table 2: Contraceptive method choice among current users by HIV/AIDS-related factors.
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riodic abstinence compared to counterparts who never tested, 
knew no one living with or died of HIV/AIDS, or had lower 
HIV/AIDS awareness. Those who perceive themselves to be at 
a moderate or high risk of HIV infection are more likely to use 
condoms (25%) than those who perceive themselves to be at no 
or low risk (14%).
 Multivariate results based on multinomial regression 
analysis (Table 3) reveals independent associations between 
HIV/AIDS-related factors and contraceptive method choice, 
once background socio-economic and demographic factors are 
controlled for. The parameter estimates from multinomial Lo-
gistic regression are presented in the form of relative risk (RR) 
factors, with 95% confidence intervals, to ease interpretation. A 
relative risk factor greater than 1.00 implies that the factor is 
associated with higher use of a particular contraceptive method 
than the reference category (i.e. hormonal method), while a val-
ue less than 1.00 implies lower use.
 The results suggest that HIV status is a significant de-
terminant of method choice, with HIV-positive women being 
more likely to use condoms or periodic abstinence rather than 
hormonal contraceptives (pills or injectables). Women who are 
HIV-positive are more than twice as likely to use condoms rather 
than hormonal contraceptives compared to their counterparts of 
similar characteristics who are HIV-negative (RR=2.41). There 
Parameter (reference categories in 
brackets)
Condom Periodic abstinence Sterilization/other
RR (95% CI of RR) RR (95% CI of RR) RR (95% CI of RR)
2008 survey (2003) 3.45 (2.29, 5.21) * 0.91 (0.68, 1.21) 0.75 (0.58, 0.96) *
HIV positive (negative) 2.41 (1.58, 3.67) * 1.58 (1.02, 2.46) * 1.17 (0.78, 1.77)
Previously tested (no) 1.12 (0.84, 1.49) 0.71 (0.55, 0.91) * 1.07 (0.85, 1.35)
HIV awareness (lowest)
- lower
- higher
- highest
0.88 (0.58, 1.34)
1.01 (0.66, 1.52)
0.76 (0.50, 1.15)
0.78 (0.55, 1.11)
0.87 (0.61, 1.24)
0.60 (0.42, 0.87) *
0.97 (0.68, 1.38)
1.05 (0.73, 1.50)
1.02 (0.72, 1.46)
Perceived HIV /AIDS mod-high risk 
(no-low) 1.02 (0.76, 1.35) 0.98 (0.77, 1.26) 0.96 (0.76, 1.20)
Age group (15-24)
- 25-34
- 35+
1.23 (0.85, 1.77)
2.58 (1.61, 4.16) *
1.19 (0.83, 1.72)
2.59 (1.66, 4.03) *
2.22 (1.41, 3.48)
5.30 (3.23, 8.69)
*
*
Parity (0)
 - 1-2
- 3-4
- 5+
0.06 (0.03, 0.10)
0.02 (0.01, 0.05)
0.02 (0.01, 0.04)
*
*
*
0.13 (0.07, 0.24)
0.10 (0.05, 0.20)
0.17 (0.08, 0.35)
*
*
*
0.24 (0.10, 0.55)
0.23 (0.10, 0.56)
0.34 (0.14, 0.85)
*
*
*
Education (none)
- Primary
- Sec+
1.16 (0.51, 2.63)
1.31 (0.56, 3.06)
1.44 (0.75, 2.76)
1.64 (0.83, 3.23)
0.70 (0.41, 1.20)
0.97 (0.55, 1.70)
Wealth index (poorest)
- Poorer
- Middle
- Richer
- Richest
0.93 (0.54, 1.59)
0.68 (0.39, 1.18)
0.90 (0.52, 1.54)
0.72 (0.39, 1.34)
0.91 (0.57, 1.45)
0.77 (0.48, 1.23)
0.77 (0.48, 1.22)
0.65 (0.37, 1.12)
0.77 (0.48, 1.22)
0.66 (0.42, 1.05)
1.06 (0.68, 1.67)
0.99 (0.59, 1.66)
Religion (Catholic)
- Protestant
- Muslim/ Other
0.83 (0.62, 1.13)
1.66 (0.97, 2.85)
0.83 (0.63, 1.08)
1.52 (0.93, 2.50)
1.20 (0.93, 1.54)
1.78 (1.07, 2.96) *
Ethnic group (Kikuyu)
- Luhya
- Luo
- Other
2.23 (1.21, 4.45)
4.42 (2.46, 8.30)
2.19 (1.33, 3.60)
*
*
*
1.16 (0.65, 2.09)
1.64 (0.91, 2.97)
1.57 (1.03, 2.40) *
0.49 (0.29, 0.83)
0.60 (0.36, 1.02)
0.74 (0.52, 1.07)
*
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is little evidence that the other HIV/AIDS factors relating to 
HIV/AIDS awareness, previous testing for HIV or HIV/AIDS 
risk perception have a significant association with choice of 
condoms or other contraceptive methods (i.e. sterilization and 
other) versus hormonal contraceptives. However, those with 
higher HIV/AIDS awareness (RR=0.60) or previously tested for 
HIV (RR=0.71) are less likely to use periodic abstinence versus 
hormonal methods, compared to their counterparts of similar 
characteristics who have lower HIV/AIDS awareness or never 
been previously tested for HIV.
 The results show little evidence of significant varia-
tions in contraceptive method choice by background socio-eco-
nomic factors controlled for in the analysis such as urban/rural 
residence, educational attainment or household wealth, once 
the effects of other important factors are controlled for. How-
ever, there is some evidence of method choice being affected by 
ethnicity, religion and region of residence. Women of all ethnic 
groups are significantly more likely to use condoms rather than 
hormonal contraceptives, compared to Kikuyu women of similar 
characteristics.
 Although age and parity are expected to be positive-
ly correlated, they show opposite patterns on method choice. 
Higher parity is associated with lower use of condoms, periodic 
abstinence and sterilization/other methods versus hormonal con-
traceptives, while the opposite is the case for older age. Those 
who want more children in future are more likely to use periodic 
abstinence (RR=1.64) and less likely to use sterilization/other 
(RR=0.61) versus hormonal contraceptives. Those who are cur-
rently married are less likely to use condoms versus hormonal 
than never married women of similar characteristics (RR=0.15 
for monogamous married; RR=0.21 for polygamous married). 
Also, the previously married (i.e. divorced/separated and wid-
owed) are less likely to use condoms (RR=0.54) or abstinence 
(RR=0.45) than the never married counterparts of similar char-
acteristics.
Correlates of Contraceptive Method Choice among HIV-Positive 
Women
 An examination of contraceptive method choice among 
HIV positive women by HIV/AIDS related factors (Table 4) 
provides no evidence of significant variations by HIV/AIDS 
knowledge or knowing someone who has died of or living with 
HIV. However, HIV risk perception in marginally significant 
(p<0.1), suggesting that those who perceived themselves to be 
at moderate or high risk of HIV infection were more likely to 
use condoms and less likely to use hormonal contraceptives than 
those who perceived themselves to be at no or low risk. More 
conclusive patterns were observed with respect to previous HIV 
testing, with HIV-positive women who were previously tested 
for HIV being more likely to use condoms and less likely to 
use hormonal contraceptives than those who have never been 
tested (p<0.05). The importance of previous HIV testing is fur-
ther highlighted in Figure 1, comparing contraceptive method 
choice of HIV-positive and HIV-negative women by previous 
HIV testing.
 Figure 1 reveals that there is no difference in method 
Region (Central)
- Nairobi
- Coast
- Eastern/North Eastern
- Nyanza
- R.Valley
- Western
1.58 (0.83, 3.04)
1.26 (0.63, 2.50)
0.92 (0.46, 1.83)
1.27 (0.64, 2.54)
1.82 (0.97, 3.42)
2.02 (0.93, 4.39)
1.10 (0.61, 1.98)
0.87 (0.48, 1.58)
0.66 (0.38, 1.16)
0.67 (0.37, 1.24)
1.99 (1.22, 3.27)
0.72 (0.35, 1.45)
*
1.38 (0.85, 2.25)
0.92 (0.54, 1.55)
0.61 (0.37, 1.00)
1.58 (0.95, 2.62)
1.18 (0.76, 1.82)
1.79 (0.98, 3.25)
*
Urban residence (rural) 1.08 (0.70, 1.66) 1.12 (0.75, 1.67) 0.88 (0.62, 1.25)
Want another child (no) 0.86 (0.64, 1.17) 1.64 (1.24, 2.16) * 0.61 (0.46, 0.81) *
Marital status
- married-monogamous
- married-polygamous
- div./sep./widowed
0.15 (0.09, 0.26)
0.21 (0.11, 0.42)
0.54 (0.30, 0.95)
*
*
*
0.82 (0.46, 1.44)
0.54 (0.27, 1.09)
0.45 (0.22, 0.92) *
1.98 (0.89, 4.42)
2.35 (1.00, 5.55)
1.45 (0.62, 3.43)
Last sexual activity (within one week)
- within one month
- 1-6 months
- > 6 month
1.21 (0.87, 1.70)
1.33 (0.87, 2.04)
0.52 (0.28, 0.95) *
1.32 (0.98, 1.78)
1.67 (1.10, 2.52)
1.52 (0.85, 2.72) *
1.37 (1.05, 1.78)
1.20 (0.79, 1.83)
1.58 (0.92, 2.73)
*
Table 3: HIV/AIDS and other determinants of contraceptive method choice.
* - sig at 5% level (p<0.05)
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HIV/AIDS factor
Method currently used (percent) Cases 
Hormonal condoms abstain other
Previously tested for HIV*
- No
- Yes 
46.0
37.9
19.0
37.1
16.0
12.9
19.0
12.1
107
148
Knows someone who has or died of HIV/AIDS (ns)
- No
- Yes 
45.9
41.2
27.0
30.7
16.2
12.1
10.8
16.1
37
216
HIV/AIDS awareness(ns)
- Lowest
- Lower
- Higher
- Highest 
30.6
49.0
40.3
43.2
36.1
27.5
30.6
27.2
22.2
7.8
15.3
12.3
11.1
15.7
13.9
17.3
35
55
76
89
Perceived HIV/AIDS risk (†)
- Mod-high or has AIDS 
- No-low risk
37.2
49.4
34.6
20.0
14.7
12.9
13.5
17.6
157
98
All 41.5 29.5 14.1 14.9 255
Table 4: Method choice among HIV-positive current users by HIV/AIDS-related factors.
*Chi-Square p<0.05; **p<0.01; ***p<0.001; † p<0.10.
Figure 1: Comparing contraceptive method choice of HIV-positive and HIV-negative women by previous HIV testing.
choice between HIV-positive and HIV-negative women who 
never previously tested for HIV, but notably higher use of con-
doms (37% vs 19%) accompanied with lower use of hormonal 
methods (38% vs 46%) among HIV-positive than HIV-negative 
women previously tested for HIV. These patterns suggest that 
the observed higher use of condoms rather than hormonal con-
traceptives by HIV-positive compared to HIV-negative women 
(Tables 2 and 3) only applies to those previously tested for HIV.
A further examination of contraceptive method choice among 
HIV-positive women by background characteristics (Table 5) 
reveal important patterns by a number of factors. Highly signifi-
cant associations (p<0.001) are observed with respect to parity, 
marital status and year of survey, with condom use being nota-
bly higher than use of hormonal methods among those of parity 
zero (90.5% condoms vs 9.5% hormonal), never married wom-
en (66.7% vs 23.3%) and in 2008 (40.9% vs 29.9%). Observed 
trends suggest a notable shift from use of hormonal methods 
to condoms by HIV-positive women. In 2003, a large majority 
of HIV-positive women using contraceptives were using hor-
monal methods (61%), with only a small minority (9%) using 
condoms. By 2008, these patterns had reversed, with condom 
use increasing from 9% to 41%, while use of hormonal methods 
declined from 61% to 30%.
 Evidence of significant associations (p<0.05) are also 
observed with respect to age group, educational attainment and 
ethnic group. Higher use of condoms than hormonal methods is 
observed among women with at least secondary education (con-
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Background characteristic
Contraceptive method currently used (%)
Unweighted Cases
Hormonal Condoms Abstinence Other
Survey year ***
 - 2003
 - 2008
61.1
29.9
9.3
40.9
12.8
14.9
16.3
14.3
84
171
Age group *
- 15-24
- 25-34
- 35+
60.0
41.2
33.3
22.5
33.3
27.6
15.0
9.6
19.5
2.5
15.8
19.5
41
118
96
Parity ***
 - 0
 - 1-2
 - 3-4
 - 5+
9.5
48.1
52.0
33.3
90.5
28.6
22.7
19.7
0.0
11.7
12.0
22.7
0.0
11.7
13.3
24.2
22
80
83
70
Education *
- none / Primary
- Sec+
45.6
34.4
24.4
38.8
16.8
10.0
13.4
16.7
160
95
Wealth index (ns)
- poorest / Poorer
- Middle
- Richer
- Richest
32.6
37.1
41.7
46.6
30.2
25.7
31.7
29.1
14.0
17.1
13.3
13.6
23.3
20.3
13.3
10.7
47
37
60
111
Religious affiliation (ns)
- Catholic
- Protestant/Muslim/ Other
41.5
41.5
33.8
27.8
7.7
16.5
16.9
14.2
72
183
Ethnic group **
- Kikuyu
- Luhya
- Luo
- Other
40.0
25.0
37.9
56.2
22.5
28.1
39.8
18.8
10.0
21.9
13.6
14.1
27.5
25.0
8.7
10.9
46
38
100
71
Region of residence (ns)
- Nairobi
- Central
- Coast/ Eastern/N. Eastern
- Nyanza
- R.Valley
- Western
43.9
42.9
50.0
36.7
41.0
39.1
29.3
21.4
23.3
40.5
23.1
21.7
9.8
10.7
16.7
12.7
25.6
13.0
17.1
25.0
10.0
10.1
10.3
26.1
43
30
38
84
27
33
Residence
- rural 
- urban
36.6
50.0
31.4
26.1
16.3
10.2
15.7
13.6
143
112
Want another child †
- no /later
- yes
39.6
44.6
31.5
26.1
10.7
19.6
18.1
9.8
159
96
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Marital status ***
- never married
- married
- div./sep./widowed
23.3
43.6
45.9
66.7
20.1
34.4
6.7
18.8
4.9
3.3
17.4
14.8
34
162
59
Last sexual activity
- within one week
- within one month
- 1-12 months
47.0
37.1
34.4
26.6
30.6
34.4
14.5
16.1
11.5
12.0
16.1
19.7
130
60
65
Total 41.5 29.5 14.1 14.9 255
Table 5: Contraceptive method choice among HIV-positive women by background characteristics.
*Chi-Square p<0.05; **p<0.01; ***p<0.001; † p<0.10.
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doms -38%; hormonal -34%) and among the Luo ethnic group 
(condoms -40%; hormonal -38%). With respect to age group, 
contraceptive method choice among the youth is potentially of 
concern. A large majority of HIV-positive young women aged 
15-24 using contraceptives are using hormonal methods (60%) 
while only 23% are using condoms.
DISCUSSION AND CONCLUSIONS
 The main objectives of the research reported in this 
paper were to: (i) examine the effect of HIV/AIDS on contra-
ceptive method choice in Kenya; and (ii) Identify correlates of 
contraceptive method choice among HIV-positive women using 
contraceptives. The analysis of contraceptive method choice 
among current contraceptive users mainly aimed at ascertaining 
the extent to which HIV-positive women are using appropriate 
methods, commensurate with their reproductive goals and needs. 
Although dual use of condoms and other contraceptive methods 
would be of primary interest, inclusion of this classification was 
not possible, given the very small numbers using dual methods. 
Overall patterns of method choice are consistent with expected 
patterns, with women who are HIV-positive being more than 
twice as likely to use condoms rather than hormonal contracep-
tives compared to their counterparts who are HIV-negative. The 
observed higher use of condoms by HIV-positive women, espe-
cially those who know their HIV status, is consistent with find-
ings elsewhere in Africa.17,21 For example, Lopez et al17 observed 
that HIV-positive women were more likely to discontinue their 
hormonal contraceptives, and more likely to use condoms. 
 Important demographic and socio-economic correlates 
of contraceptive method choice among HIV-positive women 
include parity, marital status, age group, education and ethnic-
ity. Condom use is notably higher than use of hormonal meth-
ods among those of parity zero (condoms -90.5% vs hormonal 
-9.5%), never married women (66.7% vs 23.3%), those with at 
least secondary education (38% vs 34%) and among the Luo eth-
nic group (40% vs 38%). Overall prevailing trends in contracep-
tive method choice among HIV-positive women in Kenya which 
suggest a notable shift from use of hormonal methods to con-
doms, and the observed lower use of hormonal methods by HIV-
positive compared to HIV-negative women are encouraging, 
especially given the possible link of hormonal contraception to 
increased risk of HIV infection in previous research8,9,13 and in-
creasing popularity and dominance of injectable contraceptives 
in most SSA countries, including Kenya.14-16 Recent research 
evidence has been inconclusive, calling for further research to 
establish safety of hormonal contraceptives for HIV-positive 
women.22,23
 However, observed patterns also identify some sub-
groups of HIV-positive women in Kenya for whom contracep-
tive method choice is potentially of concern. First, the fact that 
a large majority (60%) of HIV-positive young women aged 15-
24 using contraceptives are using hormonal methods and only 
23% using condoms suggests that contraceptive method choice 
among HIV-positive youth is potentially of concern. It raises an 
issue on the extent to which HIV-positive youth in Kenya are 
able to access suitable contraceptive methods, commensurate 
with their reproductive needs and desires. Although Condom 
use is recognized as one of the main strategies for combating the 
spread of HIV, promoting condom use among the youth in Ke-
nya can be controversial, especially as some believe it encour-
ages early sexual experimentation.16 Nevertheless, our findings 
provide credence to an earlier recommendation on the need for 
particular attention to reproductive health information and ser-
vices for HIV-positive adolescents.24 Second, the relatively low 
condom use among sub-groups that are known to have particu-
larly high HIV prevalence such as previously married women25 
is also of concern and warrants attention.
 It is important to recognize than although use of con-
doms is recommended for HIV-positive individuals for preven-
tion of HIV transmission, it is one of the least effective con-
traceptive methods. In a study in South Africa, Schwartz et al26 
observed that women who reported condom use were just as 
likely to have an unplanned pregnancy as women who reported 
using no contraception at all. Use of dual methods, combining 
condoms with other contraceptive methods, is preferred to im-
prove contraceptive effectiveness.27 However, dual method use 
in most sub-Saharan settings is low.21,28 A recent study in Na-
mibia, Kenya and Tanzania observed low dual method use and 
low use of highly effective contraception among people living 
with HIV for whom contraceptive protection was predominantly 
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through condom-only use.28 Dual contraceptive use in Kenya is 
very low as some couples believe it is unnecessary.29 Ralph et al9 
highlighted the need for future priorities to include expanding 
contraceptive choice and identifying effective ways of promot-
ing use of dual methods. Besides condoms, use of other con-
traceptive methods, especially long-term methods, have been 
promoted for women living with HIV. For instance, Kimani et 
al6 recommended greater use of long-term reversible contracep-
tives to reduce the risk of both vertical transmission of HIV as 
well as unintended pregnancy, while Siveregi et al7 recommend-
ed promoting long-term permanent methods in family planning 
counselling for both HIV-positive and HIV-negative women to 
improve overall contraceptive uptake and reduce unintended 
pregnancies. Kimani et al6 underscored the need to strengthen 
family planning services for women living with HIV to improve 
access to wide-ranging appropriate family planning services. 
 The observed patterns with respect to previous HIV 
testing underscore the importance of HIV testing in enabling 
HIV-positive women choose suitable contraceptive methods. 
The higher use of condoms and lower use of hormonal meth-
ods among HIV-positive than HIV-negative women previously 
tested for HIV, while there is no difference in method choice 
between HIV-positive and HIV-negative women who never pre-
viously tested for HIV, suggests that the observed higher use of 
condoms rather than hormonal contraceptives by HIV-positive 
women is only applicable to those previously tested for HIV. This 
is consistent with finding from a recent study of the effects of the 
HIV treatment on contraceptive choice in South Africa, where 
an increase in contraceptive use (especially condoms) across the 
cascade, from lowest level among HIV-positive women who did 
not know their status to highest levels among women who had 
been on HIV treatment for a long period of time was observed.27 
Similar findings have been observed in Malawi where women’s 
knowledge of their HIV-positive status was found to be a sig-
nificant predictor of their family planning practice.30 Knowledge 
of HIV status is a prerequisite for appropriate action to address 
HIV-positive status. Despite a rising trend in HIV testing in Ke-
nya and almost everyone previously tested having received their 
test results,16 a significant proportion of women of reproductive 
age (e.g. more than 40% in 2008) has never been tested for HIV, 
highlighting the need to intensify efforts to improve coverage 
in HIV counselling and testing in the country to enable women 
make informed choices to achieve their reproductive needs and 
desires.
 Finally, some key data limitations which may have po-
tential implications on our interpretation of some of the study 
findings are worth noting. First, the KDHS data used in this study 
are based on a cross-sectional design which limits our ability to 
establish temporal ordering of events of interest. We recognize 
that HIV/AIDS factors and contraceptive behaviour are intrinsi-
cally linked and while in this paper our focus is on the role of 
HIV/AIDS-related factors in influencing contraceptive method 
choice, we recognize that contraceptive behaviour (especially 
condom use) may indeed influence the risk of HIV infection. 
Therefore, we are unable to infer precise causal relationships 
from the patterns observed. It is important to recognize that the 
relationships observed provide evidence of simple associations 
rather than causal relationships. A second limitation relates to 
inadequate sample size which limits our statistical power to de-
tect some important patterns in contraceptive method choice, 
especially among HIV-positive women. Even after pooling data 
across the two surveys, the sample of 255 HIV-positive women 
using contraceptives at the time of surveys is limited for mean-
ingful multivariate analysis that would simultaneously take into 
consideration the effects of potential confounding factors in the 
relationships observed. Nevertheless, the bivariate associations 
provide useful patterns to enable identification of specific sub-
groups that should be targeted by specific family planning and 
HIV/AIDS policies and programmes in Kenya and similar set-
tings in SSA.
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